Fundz

Fundz Deep Dive

Everything you need to win Singapore Eye Research Institute (SERI) and Carl Zeiss Meditec AG — in one platform.

Who to reach, what to say, and why now on Singapore Eye Research Institute (SERI) and Carl Zeiss Meditec AG — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Singapore Eye Research Institute (SERI) and Carl Zeiss Meditec AG — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

SERI and Carl Zeiss Meditec Collaborate on Ophthalmic Tech Innovation in Singapore

Nov 15, 2024•over 1 year ago

Contract Type

partnership

SingaporeBiotechnologyHealth Care

Description

The strategic partnership, titled Ophthalmic Tech Innovation by ZEISS and SERI (OPTIZS), aims to improve surgical outcomes in refractive and cataract surgeries, with a focus on enhancing clinical outcomes and driving innovation in ophthalmic surgery. The collaboration is supported by a combined funding of nearly 20 million SGD under Singapore's Research, Innovation and Enterprise 2025 Plan (RIE 2025) and will support several research projects over the next three years.

Company Information

Company

Singapore Eye Research Institute (SERI) and Carl Zeiss Meditec AG

Location

Singapore

About

Singapore Eye Research Institute (SERI) and Carl Zeiss Meditec AG are collaborating to advance surgical outcomes in refractive and cataract surgeries, combining their expertise and funding under Singapore's Research, Innovation and Enterprise 2025 Plan (RIE 2025).

Predictive Intelligence
Strategic

ML-powered predictions for Singapore Eye Research Institute (SERI) and Carl Zeiss Meditec AG's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.